Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Addition of a dipeptidyl peptidase-4 inhibitor, sitagliptin, to ongoing therapy with the glucagon-like peptide-1 receptor agonist liraglutide: A randomized controlled trial in patients with type 2 diabetes
However, the reduction of the intermolecular disulfide of Prx is specific to Trx and cannot be achieved by GSH or Grx (Chang et al., 2004
Funding This study was supported by the Indian Council of Medical Research (ICMR: Grant No
& Stecher, B
US$ 22.95
US$ 28.71
US$ 20.76
US$ 29.02
US$ 25.88
US$ 22.12
US$ 24.78
US$ 24.62
US$ 26.66
